aDepartment of Oncology, Oncology 1, Veneto Institute of Oncology IOV-IRCCS
bDepartment of Surgery, Oncology and Gastroenterology (DiSCOG), University of Padua
cDepartment of Medicine, Nuclear Medicine Unit, University-Hospital of Padova
dNeurosurgery Department, University of Padua
eClinical and Experimental Oncology and Immunology PhD Program, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy
Received 13 April 2022 Revised form accepted 13 April 2022
*Dr. Giulia Cerretti and Dr.Diego Cecchin contributed equally to the writing of this article.
Correspondence to Giuseppe Lombardi, MD, PhD, Oncology Department, Oncology 1, Veneto Institute of Oncology IOV-IRCCS, Via Gattamelata 64, 35128 Padua, Italy, Tel: +39 0498215888; e-mail: [email protected]